Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-002566
Filing Date
2024-03-20
Accepted
2024-03-20 16:22:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 9702
  Complete submission text file 0001950047-24-002566.txt   11161
Mailing Address C/O PHATHOM PHARMACEUTICALS, INC. 2150 E. LAKE COOK ROAD, SUITE 800 BUFFALO GROVE IL 60089
Business Address
Kohli Aditya (Reporting) CIK: 0001791402 (see all company filings)

Type: 144

Mailing Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118
Business Address 321 HARRISON AVE, SUITE 500 BOSTON MA 02118 (617) 213-5054
HilleVax, Inc. (Subject) CIK: 0001888012 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41365 | Film No.: 24768069
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)